In a groundbreaking advancement that reshapes our understanding of cellular metabolism and epigenetic regulation, researchers have unveiled a novel post-translational modification (PTM) known as lysine pyruvylation (Kpy). This discovery opens new vistas into how metabolic intermediates dynamically modulate protein function, linking bioenergetic fluxes directly to gene expression control. Published in Nature Metabolism, this study propels pyruvate—a central glycolytic metabolite—beyond its canonical role as an energy substrate to that of an active biochemical modifier influencing cellular homeostasis.
The regulation of protein function through PTMs constitutes a complex, dynamic layer of cellular control essential for adapting to environmental cues. While acetylation, phosphorylation, and ubiquitination have long dominated this field, recent years have witnessed a surge of interest in metabolite-driven PTMs, signaling an intimate cross-talk between metabolism and protein regulation. Lysine lactylation’s discovery previously illuminated the potential for metabolites like lactate to serve as direct protein-modifying agents, but research on pyruvate’s analogous influence remained largely nascent.
Emerging from this context, the systematic identification and characterization of lysine pyruvylation mark a pivotal extension of the metabolic-PTM paradigm. Researchers applied advanced biochemical and proteomic techniques to delineate the landscape of Kpy across mammalian cellular proteomes. Utilizing high-resolution mass spectrometry coupled with sophisticated enrichment strategies, they cataloged 88 distinct sites of Kpy modification, spanning proteins involved in diverse cellular functions beyond innate immunity, previously the sole documented sphere affected by pyruvate modification.
One of the most striking findings of the study concerns the dynamic regulation of Kpy in response to metabolic perturbations. Through experimental modulation of glycolytic flux and intracellular pyruvate concentrations, the investigators demonstrated a robust correlation between metabolic state and the abundance of lysine pyruvylation. These results not only reinforce the concept of metabolic state-dependent PTMs but also position Kpy as a sensitive molecular sensor translating glycolytic activity into functional protein regulation.
Central to the enzymatic regulation of this newly characterized PTM is the identification of both “writers” and “erasers” controlling Kpy’s installation and removal. The histone acetyltransferase family members HAT1 and p300 (EP300) were ascertained to catalyze the addition of pyruvate groups onto lysine residues, revealing a hitherto unappreciated enzymatic versatility in accommodating metabolites beyond acetyl donors. Equally vital, sirtuin 3 (SIRT3), a well-studied mitochondrial deacetylase, emerged as the principal enzyme responsible for erasing Kpy marks, indicating a tightly orchestrated regulatory circuit orchestrating pyruvylation dynamics.
Delving deeper into functional implications, the study revealed that Kpy modifications particularly impact transcriptional regulation, suggesting an epigenetic dimension to pyruvate’s influence. Modified lysine residues on histones and transcriptional regulators were found to modulate chromatin accessibility and gene expression patterns, effectively coupling cellular energetic status to epigenetic programming. This represents a paradigm shift, situating pyruvate modifications as active participants in gene regulatory networks.
The characterization of lysine pyruvylation enriches the existing compendium of metabolite-driven PTMs, such as acetylation, succinylation, and lactylation, by adding a layer that directly reflects glycolytic flux. This emerging modification establishes a biochemical and functional continuum that integrates core metabolic pathways with the regulation of proteomic structure and activity, thereby refining our understanding of how cells dynamically negotiate resource availability with functional demands.
Notably, the enzymatic interplay involving HAT1, EP300, and SIRT3 underscores the complexity of PTM regulation within cellular microenvironments. The ability of histone acetyltransferases to transfer pyruvate—distinct from their canonical acetyl substrates—not only expands their catalytic repertoire but also invites questions about substrate specificity and the molecular determinants guiding these novel modifications. Similarly, SIRT3’s activity in removing Kpy highlights sirtuins’ broader regulatory functions beyond deacetylation, positioning them as versatile metabolic sensors and modulators.
Beyond molecular mechanistics, the discovery of Kpy has profound implications for understanding diseases such as cancer, metabolic disorders, and immune dysfunctions where metabolic reprogramming is prevalent. Given both the centrality of pyruvate in metabolism and the reversible nature of these modifications, targeting the enzymes responsible for Kpy modulation opens potential therapeutic avenues. Selective manipulation of Kpy “writers” or “erasers” could finely tune metabolic-epigenetic circuits, influencing cell fate decisions and pathological progression.
The study also sets a precedent for the development of analytical methodologies tailored to identify and quantify novel PTMs driven by small-molecule metabolites. By combining proteomic screening with functional assays, the researchers provide a robust framework for future explorations of metabolite-associated modifications, facilitating the discovery of additional uncharted PTMs and their biological contexts.
Intriguingly, this research bridges a critical gap in metabolic signaling by revealing how pyruvate, classically viewed as a metabolic intermediate funneled into the tricarboxylic acid cycle or lactate production, directly enacts regulatory roles at the protein level. This mechanistic insight refines the traditional metabolic map to encompass regulatory chemical modifications that act as molecular switches coordinating metabolism with gene expression and protein activity.
As the field moves forward, questions naturally arise about the kinetics, structural specificity, and cellular localization of lysine pyruvylation. How universal is this modification across different cell types and organisms? What signaling pathways influence its deposition and removal? And how does Kpy integration affect the broader PTM interplay governing proteomic versatility? These queries pave the way for extensive investigations at the interface of metabolism, epigenetics, and cellular physiology.
In addition to its fundamental scientific impact, the discovery of lysine pyruvylation holds promise for biomarker development. Fluctuations in Kpy levels could reflect metabolic states or disease progression, providing a novel diagnostic window. The specificity of pyruvylation sites might further inform personalized medical strategies aimed at correcting metabolic-epigenetic dysregulation.
Complementing its biochemical role, Kpy may influence protein-protein interactions, subcellular localization, and protein stability, thereby broadening the scope of pyruvate’s regulatory reach. Elucidating these effects will require integration of biophysical studies with cellular and organismal models to capture the full spectrum of functional consequences arising from this novel PTM.
The identification of Kpy underscores the increasingly recognized principle that metabolites serve dual functions—not only as substrates fueling metabolic pathways but also as chemical modifiers that convey regulatory information. This duality enriches our grasp of cellular complexity and prompts a reevaluation of metabolic dynamics with an expanded conceptual toolkit.
Ultimately, lysine pyruvylation exemplifies the intricate symphony of biochemical modifications choreographed by metabolic states to orchestrate cellular behavior. Its discovery heralds a new era in molecular biology where metabolism and epigenetics are interwoven with unprecedented intricacy, creating nuanced regulatory networks critical for health and disease.
This advance also invites the scientific community to consider the broader implications of small-molecule metabolite modifications for therapeutic intervention. Targeting metabolic modifiers like pyruvate—beyond their traditional catabolic and anabolic roles—may yield innovative strategies for modulating protein function in real time, presenting an exciting frontier that bridges chemistry, biology, and medicine.
In sum, the systematic elucidation of lysine pyruvylation redefines our understanding of how glycolytic metabolites govern protein function and epigenetic landscapes. This landmark research not only enriches fundamental knowledge but also lays the groundwork for translational breakthroughs that harness metabolic-epigenetic crosstalk to manipulate cellular fate with precision.
Subject of Research: Regulation of protein function through novel post-translational modification lysine pyruvylation and its connection to glycolytic metabolism and epigenetic regulation.
Article Title: Lysine pyruvylation couples glycolytic flux to epigenetic regulation.
Article References:
Song, X., Peng, P., Zheng, H. et al. Lysine pyruvylation couples glycolytic flux to epigenetic regulation. Nat Metab (2026). https://doi.org/10.1038/s42255-026-01556-2
Image Credits: AI Generated
